Ftse Mib
34.315,24
0,00%
DAX
20.246,37
-0,33%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
103.626,26
-2,38%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Regulus Therapeutics Inc (RGLS) Regulus Therapeutics Inc (RGLS) Notizie

Regulus Therapeutics Inc

RGLS
1,65
0,01 (0,61%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/11/202414:00PRNUSRegulus Therapeutics Announces Participation at Upcoming..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:16EDGAR2Form 8-K - Current report
07/11/202422:05PRNUSRegulus Therapeutics Reports Third Quarter 2024 Financial..
24/10/202422:02EDGAR2Form 8-K - Current report
11/10/202422:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
08/10/202414:00PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
28/8/202414:00PRNUSRegulus Therapeutics Announces Participation at Two..
08/8/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:16EDGAR2Form 8-K - Current report
08/8/202422:05PRNUSRegulus Therapeutics Reports Second Quarter 2024 Financial..
06/8/202414:00PRNUSRegulus Therapeutics to Present at the Canaccord Genuity..
29/7/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202414:00PRNUSRegulus Therapeutics Announces Participation at Two..
24/6/202416:00APSThis Biotech Wasted No Time Stealing The Premarket Show
24/6/202413:00PRNUSRegulus Therapeutics Announces Positive Topline Data from..
04/6/202414:00PRNUSRegulus Therapeutics Announces Expected Addition to the..
21/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/5/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:02EDGAR2Form 8-K - Current report
16/5/202414:00PRNUSRegulus Therapeutics Announces Promotion of Rekha Garg,..
09/5/202422:54EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:15EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSRegulus Therapeutics Reports First Quarter 2024 Financial..
06/5/202414:00PRNUSRegulus Therapeutics Advances to Cohort 4 of Phase 1b..
30/4/202414:00PRNUSRegulus Therapeutics to Participate in the Canaccord Genuity..
21/3/202421:05PRNUSRegulus Therapeutics Reports Fourth Quarter and Year-End..
12/3/202411:32PRNUSRegulus Therapeutics Announces Oversubscribed $100 Million..
12/3/202411:30PRNUSRegulus Therapeutics Announces Positive Topline Data from..
19/1/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202422:05PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
27/12/202322:16EDGAR2Form S-3 - Registration statement under Securities Act of..
Apertura: 1,60 Min: 1,53 Max: 1,645
Chiusura: 1,64

La tua Cronologia

NASDAQ
RGLS
Regulus Therapeutics
TSX
PRL
Propel
BMF
FROF36
FROF36 - 01/2036
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network